ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Polymeric nanoparticles that expand to several hundred times their original size in response to a shift in pH show promise as an anticancer drug delivery system (J. Am. Chem. Soc., DOI: 10.1021/ja807416t). Mark W. Grinstaff of Boston University, Yolanda L. Colson of Brigham & Women's Hospital, in Boston, and colleagues designed the polymer nanoparticles specifically to encapsulate drug molecules. The nanoparticles are composed of cross-linked monomers studded with 2,4,6-trimethoxybenzaldehyde protecting groups. In response to a drop in pH—a condition that mimics cellular environments—the particles shed the protecting groups to expose hydrophilic hydroxyl groups. The particles then expand as they absorb water, spilling out their contents in the process. The researchers tested the particles' drug-releasing ability in mice that had been injected with doses of lung cancer cells. Mice injected with nanoparticles loaded with the anticancer drug paclitaxel developed no tumors, whereas mice that were given an equivalent dose of paclitaxel via the standard method, dissolved in an oil base, developed large tumors after 14 days.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter